Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 16/20 | 0.58 |
| ▸ | TMEM97 | Q5BJF2 | 3/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tiaramide SCHEMBL29376518 | 1.00 | NPY5R (0.58) | NPY5RTMEM97GAATSHRNPSR1 | |
| Tiaramide SCHEMBL29379184 | 0.99 | NPY5R (0.58) | NPY5RTMEM97GAATSHRNPSR1 | |
| Tiaramide SCHEMBL181916 | 0.99 | NPY5R (0.58) | NPY5RTMEM97GAATSHRNPSR1 | |
| SCHEMBL13696444 | 0.90 | NPY5R (0.61) | NPY5RTMEM97GAATSHRNPSR1 | |
| SCHEMBL8894950 | 0.89 | TMEM97 (0.58) | NPY5RTMEM97GAATSHRNPSR1 | |
| SCHEMBL11308376 | 0.88 | TMEM97 (0.57) | NPY5RTMEM97TSHR | |
| SCHEMBL11406400 | 0.88 | NPY5R (0.47) | NPY5RTMEM97 | |
| SCHEMBL11440143 | 0.88 | TMEM97 (0.47) | NPY5RTMEM97GAATSHRNPSR1 | |
| SCHEMBL11408981 | 0.86 | NPY5R (0.57) | NPY5RTMEM97GAATSHRNPSR1 | |
| SCHEMBL8902235 | 0.86 | NPY5R (0.56) | NPY5RTMEM97GAATSHRNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5348 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12226549-B2 | Synergistically cooperative compositions useful for soft tissue augmentation, drug delivery and related fields | ALTERGON S.A. (CH) | 2025-02-18 | — | — | US | claimed |
| WO-2024105529-A1 | CHEMICAL DISBUDDING OF LIVESTOCK | MASSEY UNIVERSITY (NZ) | 2024-05-23 | — | — | WO | claimed |
| US-20240041935-A1 | PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS | CREATIVE MEDICAL TECHNOLOGIES, INC. (US) | 2024-02-08 | — | — | US | claimed |
| EP-3829643-B1 | SYNERGISTICALLY COOPERATIVE COMPOSITIONS USEFUL FOR SOFT TISSUE AUGMENTATION, DRUG DELIVERY AND RELATED FIELDS | ALTERGON SA (CH) | 2023-08-30 | — | — | EP | claimed |
| EP-1931320-B1 | MICROPARTICLES WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE AND ORAL DOSAGE FORM COMPRISING THE SAME | FLAMEL IRELAND LTD (IE) | 2022-06-15 | — | — | EP | claimed |
| EP-3998932-A1 | ALKALIZATION OF URINARY BLADDER WALL PRIOR TO TREATMENT WITH INTRAVESICAL HEPARIN AND ALKALINIZED LIDOCAINE TO ENHANCE RELIEF OF BLADDER PAIN SYMPTOMS | Parsons, C. Lowell (US) | 2022-05-25 | — | — | EP | claimed |
| US-20220118155-A1 | SYNERGISTICALLY COOPERATIVE COMPOSITIONS USEFUL FOR SOFT TISSUE AUGMENTATION, DRUG DELIVERY AND RELATED FIELDS | ALTERGON S.A. (CH) | 2022-04-21 | — | — | US | claimed |
| US-20220096498-A1 | INJECTABLE SUSTAINED-RELEASE FORMULATIONS FOR TREATMENT OF JOINT PAIN AND INFLAMMATION | FORDOZ PHARMA CORP. (US) | 2022-03-31 | — | — | US | claimed |
| US-11219650-B2 | Agent for preventing or treating small intestinal injury induced by specific NSAID and PPI | BIOFERMIN PHARMACEUTICAL CO., LTD. (JP) | 2022-01-11 | — | — | US | claimed |
| CN-113795246-A | Injectable sustained release formulation for the treatment of joint pain and inflammation | 福多兹制药公司 | 2021-12-14 | — | — | CN | claimed |
| WO-1996024336-A1 | NSAID NANOPARTICLES | NANOSYSTEMS L.L.C. (US) | 1996-08-15 | — | — | WO | claimed |
| WO-1996024339-A1 | COMPOSITIONS COMPRISING NANOPARTICLES OF NSAID | NANOSYSTEMS L.L.C. (US) | 1996-08-15 | — | — | WO | claimed |
| US-5543417-A | 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent | MERCK & CO., INC. (US) | 1996-08-06 | — | — | US | claimed |
| US-5518738-A | NONSTEROIDAL ANTIINFLAMMATORY AGENTS, REDUCED GASTRIC IRRITATION | NANOSYSTEM L.L.C. (US) | 1996-05-21 | — | — | US | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| EP-0644755-A1 | SURFACE MODIFIED NSAID NANOPARTICLES. | EASTMAN KODAK CO (US) | 1995-03-29 | — | — | EP | claimed |
| EP-0341745-B1 | Crosslinked carboxy polysaccharides | FIDIA SPA (IT) | 1994-12-14 | — | — | EP | claimed |
| WO-1993025190-A1 | SURFACE MODIFIED NSAID NANOPARTICLES | EASTMAN KODAK COMPANY (US) | 1993-12-23 | — | — | WO | claimed |
| US-4428951-A | TIARAMIDE IN WATER-INSOLUBLE OIL OR WAX | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-01-31 | — | — | US | claimed |